ATE101653T1 - Antitumor-antibiotikum kedarcidin. - Google Patents

Antitumor-antibiotikum kedarcidin.

Info

Publication number
ATE101653T1
ATE101653T1 AT89106518T AT89106518T ATE101653T1 AT E101653 T1 ATE101653 T1 AT E101653T1 AT 89106518 T AT89106518 T AT 89106518T AT 89106518 T AT89106518 T AT 89106518T AT E101653 T1 ATE101653 T1 AT E101653T1
Authority
AT
Austria
Prior art keywords
kedarcidin
antitumor antibiotic
antibiotic kedarcidin
protein
antitumor
Prior art date
Application number
AT89106518T
Other languages
German (de)
English (en)
Inventor
Sandra June Hofstead
James Andrew Matson
Kin Sing Lam
Salvatore Forenza
James Allen Bush
Koji Tomita
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE101653T1 publication Critical patent/ATE101653T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89106518T 1988-04-12 1989-04-12 Antitumor-antibiotikum kedarcidin. ATE101653T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin
EP89106518A EP0337430B1 (en) 1988-04-12 1989-04-12 Antitumor antibiotic kedarcidin

Publications (1)

Publication Number Publication Date
ATE101653T1 true ATE101653T1 (de) 1994-03-15

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89106518T ATE101653T1 (de) 1988-04-12 1989-04-12 Antitumor-antibiotikum kedarcidin.

Country Status (24)

Country Link
US (1) US5001112A (pl)
EP (1) EP0337430B1 (pl)
JP (1) JP2850132B2 (pl)
KR (1) KR970010137B1 (pl)
CN (1) CN1034589C (pl)
AT (1) ATE101653T1 (pl)
AU (1) AU623641B2 (pl)
CA (1) CA1338262C (pl)
CY (1) CY1849A (pl)
DE (1) DE68913063T2 (pl)
DK (1) DK174751B1 (pl)
ES (1) ES2061760T3 (pl)
FI (1) FI93969C (pl)
HK (1) HK83195A (pl)
HU (1) HU201119B (pl)
IE (1) IE62912B1 (pl)
IL (1) IL89896A0 (pl)
MY (1) MY105842A (pl)
NO (1) NO174474C (pl)
NZ (1) NZ228672A (pl)
PL (1) PL161004B1 (pl)
PT (1) PT90252B (pl)
SG (1) SG30654G (pl)
YU (1) YU73989A (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
CA2414570A1 (en) * 2002-01-24 2003-04-03 Ecopia Biosciences Inc. Method, system, and knowledge repository for identifying a secondary metabolite from a microorganism
SI2349520T1 (sl) * 2008-10-27 2016-08-31 Glaxosmithkline Biologicals S.A. Postopek čiščenja za ogljikohidrat iz Streptococcus skupine A

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (pl) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
FI93969C (fi) 1995-06-26
CN1037735A (zh) 1989-12-06
EP0337430A3 (en) 1991-07-24
PT90252A (pt) 1989-11-10
FI891710A (fi) 1989-10-13
NO891462D0 (no) 1989-04-10
AU623641B2 (en) 1992-05-21
HK83195A (en) 1995-06-01
PL161004B1 (pl) 1993-05-31
IL89896A0 (en) 1989-12-15
PT90252B (pt) 1994-07-29
FI93969B (fi) 1995-03-15
NZ228672A (en) 1990-07-26
FI891710A0 (fi) 1989-04-11
MY105842A (en) 1995-01-30
CY1849A (en) 1996-03-08
CN1034589C (zh) 1997-04-16
HU201119B (en) 1990-09-28
DE68913063T2 (de) 1994-06-09
CA1338262C (en) 1996-04-23
DE68913063D1 (de) 1994-03-24
NO891462L (no) 1989-10-13
IE891157L (en) 1989-10-12
EP0337430B1 (en) 1994-02-16
SG30654G (en) 1995-09-01
JPH01317396A (ja) 1989-12-22
YU73989A (en) 1991-04-30
NO174474B (no) 1994-01-31
DK174751B1 (da) 2003-10-20
NO174474C (no) 1998-06-09
PL278782A1 (en) 1989-12-27
ES2061760T3 (es) 1994-12-16
DK173589D0 (da) 1989-04-11
JP2850132B2 (ja) 1999-01-27
IE62912B1 (en) 1995-03-08
DK173589A (da) 1989-10-13
AU3272889A (en) 1989-10-19
KR900016469A (ko) 1990-11-13
EP0337430A2 (en) 1989-10-18
KR970010137B1 (ko) 1997-06-21
US5001112A (en) 1991-03-19
HUT50880A (en) 1990-03-28

Similar Documents

Publication Publication Date Title
DE68924654D1 (de) Spezifische Protease.
EP0714665A3 (en) Osteogenic devices
FI850744L (fi) Ny hjaertfoermak-peptid.
CA2019092A1 (en) Jumper cables
AU5245186A (en) Oxidation resistant mutant proteins
EP0875567A3 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DE3569112D1 (en) 4,5-dihydro-4-oxo-2- û(2-trans-phenylcyclopropyl)amino¨-3-furancarboxylic acids and derivatives thereof
ATE101653T1 (de) Antitumor-antibiotikum kedarcidin.
DE58908428D1 (de) Sekretormutante von Escherichia coli.
GR3006045T3 (pl)
EP0358217A3 (en) Image reading apparatus
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee